Discussing Cervical Cancer Screening Options: Outcomes to Guide Conversations Between Patients and Providers

Purpose. In 2018, the US Preventive Services Task Force (USPSTF) endorsed three strategies for cervical cancer screening in women ages 30 to 65: cytology every 3 years, testing for high-risk types of human papillomavirus (hrHPV) every 5 years, and cytology plus hrHPV testing (co-testing) every 5 yea...

Descripción completa

Detalles Bibliográficos
Autores principales: Holt, Hunter K., Kulasingam, Shalini, Sanstead, Erinn C., Alarid-Escudero, Fernando, Smith-McCune, Karen, Gregorich, Steven E., Silverberg, Michael J., Huchko, Megan J., Kuppermann, Miriam, Sawaya, George F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440733/
https://www.ncbi.nlm.nih.gov/pubmed/32885045
http://dx.doi.org/10.1177/2381468320952409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440733/
https://www.ncbi.nlm.nih.gov/pubmed/32885045
http://dx.doi.org/10.1177/2381468320952409

Ejemplares similares